Go-to-Market Strategy for a Clinical Skincare Brand
Turning pharmaceutical credibility into market leadership for a clinical sunscreen brand entering India’s most trust-starved skincare category.
Overview
Lakulish Pharmaceuticals had a rare edge: pharma-grade credibility in a sunscreen market shaken by SPF controversy. The goal was to develop a comprehensive brand strategy, a go-to-market roadmap, SKU launch sequencing, and a marketing budget framework that converts lab credibility into category leadership, starting with a hero SKU on Amazon India.
Client
Lakulish Pharmaceuticals
Industry
Pharma / Skincare / D2C
Duration
72 Hours
Year
2026
Closing Thought
A great product without a strategy is just inventory. Every decision here, from platform sequencing to budget allocation, was built to make trust the brand’s most compounding asset.
01
Challenge
Position a new pharma-backed sunscreen brand in a crowded market where no player had yet claimed clinical transparency, while keeping launch budgets lean and unit economics viable.
02
Solution
We crafted a clinical trust-first brand strategy, phased the go-to-market entry across Amazon, Nykaa, and D2C, and built a detailed budget and SKU sequencing model backed by real unit economics.
03
Result
The result was a set of packaging concepts that elevate brand perception through simplicity and purpose.
Final Outcome
Designed a trust-first GTM strategy for a clinical sunscreen brand, aligning pricing, unit economics, and marketing to drive sustainable e-commerce growth.